{
    "2021-07-21": [
        [
            {
                "time": "2018-07-18",
                "original_text": "'We saw a resurgence in demand in health care systems,' Novartis CEO on Q2 earnings",
                "features": {
                    "keywords": [
                        "resurgence",
                        "demand",
                        "health care",
                        "Q2 earnings"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-19",
                "original_text": "Novartis Sets 'Positive Tone' For Second-Quarter Pharma, Shares Inch Up",
                "features": {
                    "keywords": [
                        "Positive Tone",
                        "Second-Quarter",
                        "Pharma",
                        "Shares Inch Up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "Novartis (NVS) Q2 Earnings Top Estimates as Businesses Recovers",
                "features": {
                    "keywords": [
                        "Q2 Earnings",
                        "Top Estimates",
                        "Businesses Recovers"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "Novartis Earnings Top, Drug Giant's Stock Dips Slightly",
                "features": {
                    "keywords": [
                        "Earnings Top",
                        "Stock Dips Slightly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-22",
                "original_text": "Novartis Posts Q2 Earnings Beat As Sales Pick Up; Reiterates 2021 Guidance",
                "features": {
                    "keywords": [
                        "Q2 Earnings Beat",
                        "Sales Pick Up",
                        "Reiterates 2021 Guidance"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-23",
                "original_text": "Novartis profit tops expectations as pandemic impact ebbs",
                "features": {
                    "keywords": [
                        "profit tops",
                        "expectations",
                        "pandemic impact ebbs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "Novartis aims to beat rivals to novel $10bn cancer treatment market",
                "features": {
                    "keywords": [
                        "aims to beat rivals",
                        "novel $10bn",
                        "cancer treatment market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}